# A Possible Role for the Vagus Nerve in Physical and Mental Health

## TL;DR

This paper reviews how stimulating the vagus nerve may help treat various physical and mental health conditions, though results are mixed and more research is needed.

## Contribution

The paper provides a comprehensive review of tVNS applications and mechanisms, highlighting the need for next-generation technologies and rigorous trials.

## Key findings

- Transcutaneous VNS is being tested for conditions like depression, arthritis, and long COVID-19.
- VNS modulates immune responses, mood, and neurotransmitter systems via vagal fibers.
- Next-generation closed-loop devices may improve VNS efficacy and reduce side effects.

## Abstract

For decades, researchers have explored the therapeutic potential of the vagus nerve through vagus nerve stimulation (VNS). Initially developed for epilepsy, VNS has since been applied to treat resistant depression, stroke recovery, and inflammatory conditions. Transcutaneous VNS (tVNS) now offers a noninvasive alternative, fueling clinical trials in disorders ranging from rheumatoid arthritis and migraines to long COVID-19. Mechanistic studies suggest that afferent and efferent vagal fibers modulate immune responses, mood regulation, and neurotransmitter systems. The SPARC initiative has accelerated mapping of vagal circuits, enabling more precise approaches to stimulation. Despite progress, the results remain mixed: while some patients experience lasting symptom relief, others respond no better than to placebo. Depression studies, in particular, highlight both the promise and the complexity of VNS, as inflammation, motivation circuits, and gut–brain signaling emerge as key modulators. Next-generation closed-loop devices and circuit-specific targeting may improve efficacy and reduce adverse effects. VNS research thus lies at the intersection of neuromodulation, psychiatry, and immunology—offering hope for hard-to-treat conditions, yet demanding rigorous trials to separate myths from medicine. In this article, we review the current clinical and experimental applications of tVNS, analyze its mixed efficacy across psychiatric, immunological, and neurological disorders, and highlight the mechanistic insights, stimulation parameters, and emerging technologies that may shape next-generation therapies.